Cargando…
Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
Autores principales: | Antonioli, Luca, Fornai, Matteo, Romano, Barbara, Pellegrini, Carolina, Blandizzi, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187885/ https://www.ncbi.nlm.nih.gov/pubmed/32372955 http://dx.doi.org/10.3389/fphar.2020.00448 |
Ejemplares similares
-
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021) -
Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
por: Pellegrini, Carolina, et al.
Publicado: (2019) -
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018) -
NKG2A and COVID-19: another brick in the wall
por: Antonioli, Luca, et al.
Publicado: (2020) -
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2017)